Cargando…
Profiling of Target Molecules for Immunotherapy in Mesenchymal Tumors
Autores principales: | Hayashi, Takuma, Ichimura, Tomoyuki, Sano, Kenji, Tonegawa, Susumu, Kanai, Yae, Zharhary, Dorit, Aburatani, Hiroyuki, Yaegashi, Nobuo, Konishi, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681852/ https://www.ncbi.nlm.nih.gov/pubmed/31413773 http://dx.doi.org/10.14740/jocmr3886 |
Ejemplares similares
-
Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014) -
Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Importance of diagnostic methods for round ligament leiomyomas in clinical practice
por: Hayashi, Takuma, et al.
Publicado: (2023) -
Potential role of LMP2 as tumor-suppressor defines new targets for uterine
leiomyosarcoma therapy
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice
as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011)